18 insiders reported 127 Form 4 transactions for TruBridge, Inc. (TBRG) over the past 18 months (most recent 2026-04-09). Recent activity: Fowler Christopher L (President and CEO) Buy 19,683 shares, Plessner Kevin (General Counsel) Buy 2,598 shares, Bassi Vinay (Chief Financial Officer) Buy 12,698 shares, MacIntyre Vita (Controller) Buy 909 shares, Harse David (General Manager Patient Care) Buy 5,079 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-09 | Fowler Christopher L | President and CEO | Buy | 19,683 | $0 |
| 2026-04-09 | Plessner Kevin | General Counsel | Buy | 2,598 | $0 |
| 2026-04-09 | Bassi Vinay | Chief Financial Officer | Buy | 12,698 | $0 |
| 2026-04-09 | MacIntyre Vita | Controller | Buy | 909 | $0 |
| 2026-04-09 | Harse David | General Manager Patient Care | Buy | 5,079 | $0 |
| 2026-04-09 | Wilson Merideth | Financial Health GM | Buy | 5,206 | $0 |
| 2026-04-09 | Daughton Michael | Chief Business Officer | Buy | 10,572 | $0 |
| 2026-03-30 | MacIntyre Vita | Controller | Sell | 187 | $2,631 |
| 2026-03-17 | Bassi Vinay | Chief Financial Officer | Sell | 3,965 | $69,744 |
| 2026-03-17 | Plessner Kevin | General Counsel | Sell | 340 | $5,885 |
| 2026-03-17 | Plessner Kevin | General Counsel | Sell | 825 | $14,512 |
| 2026-03-17 | Bassi Vinay | Chief Financial Officer | Sell | 1,758 | $30,431 |
| 2026-03-17 | Wilson Merideth | Financial Health GM | Sell | 604 | $10,455 |
| 2026-03-17 | Fowler Christopher L | President and CEO | Sell | 2,213 | $38,307 |
| 2026-03-17 | Fowler Christopher L | President and CEO | Sell | 5,909 | $103,939 |
| 2026-03-17 | DYE DAVID A | Director | Sell | 1,285 | $22,243 |
| 2026-03-17 | DYE DAVID A | Director | Sell | 2,793 | $49,129 |
| 2026-03-17 | Harse David | General Manager Patient Care | Sell | 571 | $9,884 |
| 2026-03-17 | Harse David | General Manager Patient Care | Sell | 1,098 | $19,314 |
| 2026-03-17 | MacIntyre Vita | Controller | Sell | 125 | $2,164 |
| 2026-03-11 | Harse David | General Manager Patient Care | Sell | 377 | $6,963 |
| 2026-03-11 | Plessner Kevin | General Counsel | Sell | 280 | $5,172 |
| 2026-03-11 | Fowler Christopher L | President and CEO | Sell | 2,093 | $38,658 |
| 2026-03-11 | DYE DAVID A | Director | Sell | 9,516 | $0 |
| 2026-03-11 | DYE DAVID A | Director | Sell | 1,416 | $26,154 |
Source: SEC Form 4 filings · as of 2026-04-09